🇮🇳IN
Sign In
BE

BETA

NSE

Beta Drugs Limited

₹1,894.60

-76.40(-3.88%)

Ownership Score

Index Membership

and the weight we carry

Mutual Fund Ownership

% of each scheme's portfolio

Insider & Deals

who traded, and how close they are to the company

Ownership & Influence

who holds it, and what else they hold

Shared directors

companies with a board member in common

BETA shareholding summary

As of Jun 2026, promoters held 59.10% of Beta Drugs Limited. Institutions together held 7.25%, of which foreign institutional investors held 1.02% (down 1.93 points from May 2026) and domestic institutions held 6.23% (up 0.22 points from May 2026). The public held the remaining 33.65% (up 1.72 points from May 2026). The company had 7,359 shareholders.

Promoters59.10%
FII1.02%
DII6.23%
Public33.65%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer